Purdue Pharma

Purdue Pharma judge approves $6-billion opioid settlement, overrules U.S. Department of Justice

Purdue’s Sackler owners propose up to $6 billion opioid settlement

Purdue Pharma judge extends Sacklers’ U.S. litigation shield to Feb. 17

Purdue Pharma seeks to appeal U.S. ruling that overturned its opioid settlement

U.S. judge refuses to allow litigation to move ahead against Purdue’s Sackler family; negotiations ordered

Judge tosses deal shielding Purdue’s Sackler family from opioid claims

How bad is Canada’s drug overdose epidemic? American-level bad

Appeals are mounting in Purdue Pharma bankruptcy settlement

Judge formally approves use of OxyContin profits to fight opioid crisis

Morning Update: Federal party leaders square off in first French-language debate

Provinces plan legal push against Purdue Pharma in wake of U.S. opioid deal

U.S. judge conditionally approves Purdue Pharma opioid settlement

Judge overseeing Purdue Pharma’s bankruptcy urges opioid plan opponents to settle with Sackler family

Purdue Pharma argues settlement better for states than continuing lawsuits

Purdue Pharma lawyer warns of long, expensive litigation

Purdue Pharma offers plan to end Sackler control and mounting lawsuits

McKinsey’s top executive voted out as consulting firm faces reckoning over opioid crisis

Either way, Dominic Barton’s plea of ignorance makes Justin Trudeau look bad

At the root of the opioid crisis is our belief that Big Pharma can cure pain. Can we kick that habit?